Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
XC8 in Uncomplicated Influenza or ARVI
NCT03441373Phase 3Completed
- Sponsor
- PHARMENTERPRISES LLC
- Start
- Feb 2016
- Primary completion
- Feb 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of histamine glutarimide in influenza, acute respiratory viral infection (ARVI), sponsored by PHARMENTERPRISES LLC. Started Feb 2016; status: completed.
02
Drugs
histamine glutarimide
03
Conditions
influenzaacute respiratory viral infection (ARVI)
Beyond the preview
Go deeper on NCT03441373.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03441373.